GS - US - 174-0144. A Randomized double blinded evaluation of the antiviral efficacy safety and tolerability of Tenofovir Disproxil Furmarate versus placebo in paediatric patient with chronic hepatitis B infection. IEC Ref. No. 359/2015
Project Description
Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.
Project Duration
2016 - 2026
Project Lead
Klinera CRO 2016
Authors
Dr. Harshad Devarbhavi & Dr. Mallikarjun
Project Status
ongoing